expect solid us stapl trend reinforc strong
result beverag result boost favor
weather solid price/mix solid gm trend across cpg
price benign commod although see weaker
preview ep preview highlight tactic opportun
head earn includ pg/nwl posit trade also continu
like post strong quarter neg side long-term
top ow rate ko/pg/mdlz/pep/el kdp/clx uw expect
gener solid cpg result reinforc strong result price
place moder commod favor weather beverag deeper
look ow/uw see deep dive thesi video ko see pg see
see see el see see
see
sector view expect top-line trend beverag aid favor
summer weather us lesser extent western europ also
continu believ beverag top-line growth acceler durabl
long-term beverag rel hpc/food greater price power
retail perspect divers channel mix tilt balanc power beverag
risk competit perspect concentr market share
beverag compani hpc still solid solid price
moder commod pressur believ mark key delin
point compani start cycl commodity-driven price increas
year ago drive clear diverg top-line trend compani
gain market share ow-rat pg vs compani struggl
 uw-rat food remain top pick build
momentum emerg market overweight remaind
food group us center store trend still pressur
multi-national compani fx pressur particularli top mind
investor given recent dollar strength view fx major issu
point clear risk factor could threaten start overwhelm
individu stock stori stronger dollar continu
short-term trade opportun believ best short-term trade
quarter long pg/nwl cautiou call
becom consensu still believ make sens tactic head
procter gambl pg expect continu strong top-line growth
least probabl even rang gross margin upsid vs
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
consensu expect solid back-to-school season
eas market fear around ep visibl mse ep consensu
neg side keurig dr pepper expect soft coffe top-line
trend revers shipment time benefit weak coffe
margin deliveri reinvest behind k-duo launch
ko top us beverag pick top pick us beverag ko see
latest note note potenti inflect upgrad ow
detail see ep growth inflect convers
improv beyond key posit catalyst also believ ko
offer clearli superior top-line growth outlook vs cpg peer stronger
price power favor strategi tweak believ reflect
rel valuat long-term histor averag pleas also see
recent deep-div video deep dive review ko top pick beverag
pg top us hpc pick top pick hpc procter gambl pg
believ pg organ sale growth trajectori sustain improv strong
breadth across portfolio expand market share despit higher price
peer combin above-consensu inflect gross margin
base detail gm build expect higher pg ep growth peer
support multipl expans peer time pleas see recent note
visibl peer top-line growth gm recoveri build deep-div
video deep dive review procter gambl pg top pick household product
 reiter ow detail
top us food pick food mondelez top pick posit
strategi chang gain traction believ begin
stage organ sale growth acceler aid recent reinvest
well favor geographic/categori growth footprint
result sustain higher top-line growth multipl expans market
shift multi-national cpg peer set lower growth us-centr food peer
pleas see recent upgrad ow note upgrad ow smart cooki
fulli appreci deep-div video deep dive review mondelez top
pick food reiter ow detail
/el ow idea also continu like pepsi-cola
alreadi report strong result see note continu solid
top-line momentum us snack intern growth remain robust
climb corpor mix profit detail see
recent note deep-div video lauder el believ
market undervalu est lt growth potenti favor exposur
high growth channels/geographi within high growth prestig beauti
acknowledg less stock upsid previous mention name given el
valuat premium vs hpc peer recent see recent note
china beauti note deep-div video
 top uw idea uw side top idea
keurig dr pepper believ market overestim lt growth
potenti limit revenu growth ebitda margin expans
synergy-rel growth dissip next coupl year also believ
market appropri factor high risk level larg
deal recent dp high debt leverag aggress assumpt full drop-
cost synergi bottom line top base busi growth
well given opaqu coffe busi model detail pleas see
deep-div video deep dive review keurig dr pepper reiter uw
see risk stretch valuat see
widen fundament gap peer deceler growth track channel
lower gm expans price dissip fulli reflect in-lin
valuat hpc peer recent note analyst day takeaway
categori deep dive reveal increas breadth magnitud top-lin
exhibit ep ms estim chang current quarter current fy
tabl content
beverag household product packag food
mute stock reaction quarter solid underli trend increas
fx headwind expect mute stock reaction ko result expect
solid underli trend off-set recent strengthen us
increas fx headwind particularli look estim
increment higher ep headwind fx sinc last report
total y-o-i impact nearli half expect ko abl cover
higher price emerg market stronger lt algorithm
top us beverag pick ko remain top us beverag pick behind strong
sustain msd organ sale growth potenti eps/fcf growth inflect
beyond detail ow thesi ko pleas see upgrad
note video inflect note post ep note
solid organ sale growth forecast solid underli organ
sale growth unit case volum growth price/mix base unit case
volum growth price/mix averag basi forecast
underli organ sale growth vs adjust
brexit-rel inventori build headlin organ sale
growth estim concentr sale growth price/mix growth
model concentr sale nearli bp unit case sale growth
ko cycl brazilian bottler inventori build
solid us scanner data ko us scanner data sale growth y-o-i
close
importantli averag basi growth acceler vs
albeit aid favor weather
european scanner data slower cycl sugar tax european scanner data
sale growth slow mainli cycl sugar tax uk franc
well favor summer ko sale y-o-i
versu howev
averag basi ko sale acceler vs
expect unchang organ top-line ep guidanc believ ko
reiter full-year guidanc includ organ sale growth
rais prior least compar ep growth
rang
estim updat ep estim unchang
ep estim fall reflect higher fx headwind partial
off-set benefit increment ko price emerg market strong
thought quarter
expect ep in-lin consensu
forecast y-o-i unit case volum growth includ asia pacif
north america latin america flat y-o-i underli
organ sale growth forecast unit case growth price/mix growth
forecast concentr sale nearli bp unit case sale
growth ko cycl brazilian bottler inventori build headlin
organ sale growth forecast concentr sale growth price/mix
expect y-o-i revenu growth compris underli
organ sale growth benefit ko costa acquisit partial
off-set headwind fx
forecast om contract bp y-o-i expect bp
y-o-i gm compress fx structur item mainli due
consolid philippin bp increas sg sale
driven cycl fx gain consolid lower margin busi
philippin costa partial off-set product
stronger price power peer coke price power increas
last year shift price/mix focu slower growth develop
market last three year price/mix growth ahead peer
revers unfavor bp gap believ ko
greater price power sustain focu mix price pack
architectur well favor structur driver price beverag
favor strategi tweak includ total beverag strategi believ
numer favor strategi tweak rel new ceo
includ cultur shift becom nimbl compani total beverag
focu allow penetr greater extent higher growth non-
solid volum growth outlook despit greater price ko rel low
demand elast price increas ko volum growth last two
year line mega-cap peer believ ko volum
growth outlook improv go forward ko effort diversifi
valuat still compel trade in-lin price-to-earnings vs mega-cap peer
pep/pg/cl histor premium seem clearli low given
high visibl greater organ sale ep growth potenti ko well
million except ep
sale
posit reaction bar pg high post ytd stock price
out-performance still expect posit stock reaction earn
least organ sale growth probabl closer coupl gross margin
expans upsid vs consensu albeit expect unchang fy ep
guidanc underli increas off-set fx
organ sale growth forecast organ sale growth
prior vs two-yr averag basi forecast
would surpris result given strong
scanner data posit feedback growth untrack channel
us scanner data trend remain strong look scanner data pg us trend
remain strong y-o-i us track channel sale growth
importantli averag basi pg us scanner trend acceler
vs also
view underli qualiti solid given recent us scanner data strength
accompani continu yoy pullback promot spend bp yoy
sale calendar bp declin bp
declin last believ pg momentum strengthen untrack
channel strong club channel e-commerc trend
european scanner data deceler european trend deceler
decreas average vs y-o-i
increas average increas average
decreas
gross margin inflect expect gross margin inflect pg y-o-i
gross margin bp y-o-i vs bp bp consensu
robust price moder commod pressur detail gross margin
build point bp even use conserv assumpt
estim chang price target rais rais ep
reflect slightli higher organ top-line growth margin partial
off-set neg fx rais pt base
thought quarter
ep cent consensu estim
forecast y-o-i pg organ sale growth prior
prior year comparison driven volum price
mix two-yr averag basi forecast
forecast oper margin expand bp y-o-i driven bp
y-o-i gross margin expans posit price cost save commod
benefit partial off-set fx reinvest headwind also expect sg
sale bp y-o-i
top-line momentum look sustain believ strategi tweak put place
recent year bear fruit acceler pg top-line growth back
rang long-term us improv breadth perform market
confid market share momentum sustain combin
improv price outlook greater agil organiz chang
implement support lt top-line growth hpc peer
improv margin outlook expect inflect bp gross margin
expans led price realiz slight commod benefit
bp cost save view forecast conserv base detail gm
build yet well ahead bp consensu
valuat look compel rel basi pg trade
ep line hpc peer rel valuat look compel given higher pg
growth peer
sale
million except ep
mute stock reaction expect gener solid quarter moder
commod cost solid organ sale growth think market alreadi
set high bar result consensu ep
recent rais guidanc rang expect rais
fy ep forecast may choos reinvest potenti upsid lower
organ sale growth forecast yoy average organ sale
growth reflect deceler vs time aid yoy
average still level yoy impact
volum off-set benefit price mix expect
rel solid quarter average sale growth well ahead level
deceler follow strong result given us scanner data
deceler sequenti comparison becom challeng
deceler vs level
yoy mainli due dissip price yoy vs average
us scanner sale growth also deceler slightli
north america consum assum trend untrack channel remain line
prior quarter western europ track channel scanner data sale
average
average ahead average
rais estim price rais ep estim
cent lower pulp price gross margin bp ahead prior forecast
quarter ep estim cent consensu
ep estim move cent high-end
current guidanc rang well cent consensu price
target tick
thought quarter
ep estim cent consensu
forecast organ sale growth average roughli line
consensu total sale growth bp higher consensu reflect
slight slowdown level yoy average basi
segment forecast organ sale growth person
average consum tissu average kc-profession
expect bp yoy oper margin expans see bp gross
margin expans support lower pulp price partial off-set higher sg
bp higher sale line trend cycl bp yoy
mr decreas base period
mute top-line outlook continu project long-term organ revenu growth
driven competit concern pg/privat label pressur north
america profit local compani pressur china also see mute
categori growth declin birth rate us/develop market
guidanc appear conserv estim rang
oper incom growth vs guidanc ep
valuat reflect long-term fundament trade
price-to-earnings multipl view kmb price-to-earnings discount vs higher growth hpc peer
pg/cl/chd/clx discount vs pg/cl appropri although could
see trade upsid lower input cost
million except ep
sale
note ccep provid trade updat octob ccep releas full
month result top-line result consist
mani european peer
modest posit stock reaction expect modest posit stock reaction
ccep trade updat better expect sale base solid scanner
data trend particularli consid difficult comparison
expect organ sale growth trend deceler sequenti y-
o-i vs new top-line forecast
bp consensu market well prior low-single-
digit sale declin forecast
slow organ sale growth solid consid difficult comparison
forecast organ sale growth y-o-i prior
estim reflect better expect scanner data trend difficult
comparison ccep benefit favor weather
western europ issu uk enabl ccep gain signific
market share fewer issu competitor well favor
impact world y-o-i basi forecast
howev two-year averag basi
forecast growth
proxi includ monster sale spain germani
franc uk increas y-o-i two-year averag
y-o-i growth two-year averag
growth two-year averag two-
year averag howev averag impress acceler
innov look updat ccep innov particularli
expans territori costa rtd coffe
product uk addit signatur mixer new diet flavor
market share energi drink categori western europ last four
week end prior four week
peak june countri basi reach market share spain
initi test market last four week end april
although share june market share germani
last four week sequenti prior four week market
share uk last four week june market
share franc last four week sequenti prior four
estim price target updat ep estim go
reflect higher top-line growth assumpt price
target tick base price-to-earnings base higher
thought quarter
forecast organ sale growth comparison
conserv impli growth base histor gap bp
vs ccep proxi nielsen western european scanner data
organ top-line estim bp
region basi forecast y-o-i organ sale growth iberia vs
scanner data trend organ sale growth germani vs scanner
data trend organ sale growth franc vs scanner data trend
off-set y-o-i sale declin uk conserv
scanner data trend given ccep cycl difficult
comparison consid shipment benefit issu
lt top-line lsd rang believ ccep lt top-line outlook lower vs
cpg peer given high csd-skew volum exposur
slower growth western europ health/wel concern limit csd
categori growth howev believ improv lsd lt growth forecast
reason ccep consid favor mix shift toward higher growth
nartd categori particularli energi drink ration price environ
bp margin expans per year post driven price/mix realiz
moder vs annual margin expans bp
driven synergi realiz german/spanish merger
valuat appropri reflect improv fundament outlook believ
ccep valuat price-to-earnings ev/ebitda premium
bottler peer price improv fundament solid price/mix outlook
favor mix shift toward higher growth nartd beverag
eur million
mute reaction expect mute stock reaction earn forecast
solid improv organ sale growth soft profit quarter
shift brand build quarter also see potenti risk
profit/ep guidanc impli larg improv constant currenc
profit growth vs estim
also note offici reiter guidanc septemb
us scanner data updat us scanner data growth y-o-i
vs average
basi us scanner trend slightli improv vs
price/mix growth y-o-i
average vs average
average average
organ sale growth forecast organ sale y-o-i
prior reflect slightli better us scanner data trend vs
two-year averag basi
model organ sale growth vs
organ sale forecast driven growth amea y-o-i
multipro organ base europ y-o-i north america
y-o-i in-lin us scanner data trend mute growth latin
america difficult comparison outsiz growth
parati busi lesser extent pringl
guidanc see potenti risk profit ep guidanc
given expect soft profit deliveri time brand build larg
impli profit growth improv believ point low
end constant currenc oper profit guidanc low
end constant currenc ep growth guidanc perhap lower
estim updat ep estim unchang higher
organ sale growth forecast off-set higher fx headwind lower margin
estim ep estim tick reflect higher fx
headwind slightli lower margin assumpt ep estim
consensu low end constant currenc
thought quarter
ep estim line consensu
forecast organ sale growth y-o-i y-o-i comparison
prior estim reflect slightli better us growth assumpt
two-year averag basi model organ sale growth vs
y-o-i organ sale
forecast driven growth amea y-o-i europ y-o-i
north america y-o-i in-lin us scanner data trend mute
y-o-i growth latin america cycl difficult comparison
forecast oper margin bp y-o-i estim
driven bp y-o-i gross margin contract impact
increment cost relat on-the-go packag format partial off-set revenu
growth manag benefit also model bp increas sg
sale vs larg bp y-o-i decreas time brand build spend
indic would weight partial off-set product
project save overal model oper profit ex-fx
vs
organ top-line improv believ organ top-line growth
improv growth vs flat prior two year
higher reinvest busi contribut intern
growth includ multipro acquisit bp top-line growth
lt org sale forecast midpoint guidanc
includ futur
margin inflect post cycl higher input packag cost
relat on-the-go pack format ad in-hous capac
margin headwind multipro acquisit dissip benefit
price action start flow
valuat look fair believ valuat price-to-earnings
pension adjust basi report ev/ebitda look fair
alreadi price topline/profit recoveri second half beyond
off-set limit lt growth geographies/product categori
million except ep
sale
mute stock reaction expect mute stock reaction estim
organ sale growth like stand well packag food peer
closer multi-national cpg peer howev offset solid organ sale
growth forecast higher fx headwind three-fourth
sale exposur outsid us increment bp ep headwind
also see flattish y-o-i benefit price off-set
continu product issu brazil estim bp
headwind quarter
us scanner data updat us scanner data growth
y-o-i close
average basi us scanner growth
slightli
solid organ sale growth forecast organ sale growth
vs averag basi
model organ sale growth vs
averag account recoveri malwar issu
artifici depress growth model growth vs
estim updat ep estim unchang
estim tick reflect higher fx headwind
thought quarter
ep estim in-lin consensu
forecast y-o-i organ sale growth y-o-i
comparison y-o-i organ sale growth forecast driven latin
america y-o-i europ rel easi comparison
north america close us scanner data trend asia middl east
forecast oper margin bp y-o-i driven bp
gross margin expans price benefit off-set product issu brazil
expect continu brazil product issu bp
headwind expect similar headwind also model
bp decreas total sg sale product save partial off-set
higher invest behind busi
acceler top-line growth sustain level believ
organ top-line growth acceler sustain level vs
growth rate last year driven follow item
favor geograph categori exposur exposur emerg market
snack categori strategi chang higher reinvest focu
local brand shift focu top-line margin expans chang incent
compens focu volum growth volum trend
emerg market improv market share trend improv
result higher invest global categori growth categori
improv us top-line growth trend acceler particularli
cookies/crack led price
margin expans opportun forecast bp annual
oper margin expans reinvest driven solid
top-line growth outlook continu product benefit albeit lower
histori post end larg restructur program net
reinvest busi bp annual margin expans forecast
well food peer flattish rang need reinvest
multipl year cost/a cut
valuat compel rel multi-national cpg peer believ
market incorrectli compar valuat us-centr food peer
argu topline/ep growth profil similar multi-national cpg peer
ko/pep/pg/cl valuat price-to-earnings look compel
discount multi-national cpg peer
mute stock reaction expect mute stock reaction ep
forecast profit/ep miss mse consensu off-set
improv sequenti top-line trend us albeit aid favor weather
help overal beer categori also expect hear new
ceo gavin hattersley strategi turn around top-line trend
believ center higher market spend focu innov
top-line growth forecast local currenc sale y-o-i
year-ago comparison prior reflect better us
scanner data trend us total revenu forecast
y-o-i prior reflect improv us scanner
data volum trend favor summer weather improv vs y-
o-i str declin y-o-i str forecast base histor
bp gap us scanner data volum report deplet last six
quarter forecast shipment y-o-i deplet
cycl solid stw trend us high inventori level
year ago quarter regard us price/mix forecast increas
slightli close
beer/fmb/cid scanner volum decreas y-o-i average
improv vs average average
average sale basi us beer/fmb/cid scanner
sale improv y-o-i average vs
average average average
outlook provid formal ebit/ep guidanc
ep estim consensu term key line item expect
reiter prior guidanc includ plu minu
underli free cash flow msd underli cog per hectolit increas
new ceo strategi look color strategi new ceo
gavin hattersley offici took posit septemb
last earn call mr hattersley state need consid option
take maxim futur potenti busi creat addit firepow
put behind brand order us innov plan beyond
go get detail expect new strategi
center higher market well greater focu innov speed
market goal re-acceler top-line growth howev see volum
struggl like continu given poor subcategori posit weak
estim updat ep estim unchang higher
top-line estim off-set higher mg reflect cycl favor item
year ago period ep also unchang
thought quarter
ep estim cent consensu
forecast y-o-i local currenc sale decreas driven
increas price/mix off-set volum decreas forecast
headwind fx report sale y-o-i
forecast oper margin decreas bp y-o-i bp y-o-i
gross margin declin commod inflat volum de-lever partial
off-set price bp increas mg sale driven
cycl favor resolut us vendor disput worth
mg line bp higher y-o-i market sale
weak fundament outlook growth challeng compani burden
heavi exposur us beer categori sale exacerb
unfavor posit outsiz leverag declin premium
economi segment repres us volum mix respect
backdrop forecast organ sale compound-annual-growth-rate
bottom hpc/beverag coverag univers
remain sidelin near term combin continu volum
challeng us commod cost pressur gross margin high debt
leverag like continu weigh sentiment clear catalyst
horizon fundament pressur reflect valuat remain ew
mute posit stock reaction ytd stock out-performance
expect mute posit stock reaction el expect above-guid
result rais ep guidanc model round organ sale
growth el guidanc
organ sale growth forecast el organ growth
high end el guidanc would surpris see
result two-yr averag basi model organ growth
growth
china key debat stock remain sustain growth china
fuel strong result asia pacif region organ growth
model strength segment continu albeit slow
sequenti basi y-o-i average vs
average y-o-i average growth
guidanc conserv wrote recent note este lauder
sep believ el top-line guidanc conserv
four key reason believ drive el rais top-line guidanc
high-end
guidanc assum substanti balanc year slowdown given el highlight
momentum area show sign slowdown china/travel retail earli
septemb guidanc impli bp two-yr average organ sale growth slowdown
vs even high-end see fy guidanc conserv
 balanc year slowdown vs look unrealist look past two
fiscal year el outperform high end next quarter local currenc sale
growth estim quarter averag bp assum el beat
org sale growth guidanc slightli lower bp magnitud post
growth would impli balanc year growth would need slow
bp reach high end full-year guidanc
 el emb signific headwind guidanc extern risk factor creat increas
risk would argu el alreadi factor bad case assumpt
factor includ hard brexit continu hong kong disrupt moder
china/travel retail continu challeng develop market particularli
geograph shift benefit el top-line growth el geograph mix continu pivot
higher growth region includ emea asia pacif estim
bp benefit el top-line mix shift vs also forecast
moder america declin entir due easier comparison mean two-
yr averag forecast deceler worth bp corpor organ sale growth
fx impact ep estim ep estim move
respect increasingli neg fx pt remain
thought quarter
expect ep slightli consensu el
forecast local currenc sale growth comparison
segment forecast america post local currenc declin vs
comparison emea vs comparison asia pacif
forecast oper margin expans bp y-o-i vs bp
comparison driven bp y-o-i gross margin contract off-set bp
decreas sg expens sale top-line leverag
robust organ sale growth believ investor underestim growth
potenti driven el chang channel mix favor shift much higher
growth higher margin channel e-commerc travel retail
geograph mix includ much greater growth emerg market china
specif believ drive lt revenu growth higher
market price revers dcf standpoint continu
investor concern china growth deceler rapidli recent
alphawis survey chines beauti industri show strong
premium intent younger consum increasingli interest
premium global brand underpin belief continu strong growth
ev/ebitda valuat premium vs cpg peer low given much higher
topline/ep growth potenti long-term basi
million except ep
sale
interest incom
provis incom tax
net incom non-controlling
mute stock reaction expect ep drive mute stock reaction
worri tough comparison still elev rel valuat vs
organ sale growth forecast organ sale growth
bp guidanc us track channel scanner
data deceler versu
two-year averag momentum also deceler
histor regress
nielsen scanner data report result impli organ sale growth
consum domest segment sale
forecast given see build momentum untrack channel e-commerc
two-yr average basi organ sale growth specialti difficult
us laundri categori deceler liquid laundri categori
gain bp market share
pg bp henkel bp categori price increas
promot intens
decreas categori percent sale sold promot decreas
bp yoy versu bp yoy increas bp decreas
manag also anticip promot environ
laundri second half year market share gain
dissip bp yoy bp last quarter larg
promot pullback sale promot declin bp yoy see
competit environ laundri watch point go forward particularli
henkel state reinvest plan
thought quarter
ep estim in-lin consensu
rais organ sale growth estim bp vs
comparison bp guidanc momentum pick
untrack channel expect consum domest organ sale
organ sale growth specialti product flat comparison
histor gap report result scanner data impli
consum domest organ sale growth forecast given
untrack channel e-commerc club stronger
anticip oper margin contract bp yoy bp
consensu driven moder commod pressur flat sg
sale easi comparison off-set flawless deal amort expens
solid top-line growth skew lower growth competit us market
limit lt growth although market share gain drive solid corpor
valuat reason think chd valuat ep
yield look reason given solid org sale growth
million except ep
mute stock reaction follow recent downward revis guidanc
last week analyst day see note clorox co analyst day takeaway
subsequ consensu revis believ street expect appear reason
expect chang guidanc thu expect
mute stock reaction remain uw long-term concern compani
assum us sale growth inflect may optimist detail
note categori deep dive reveal increas breadth magnitud top-lin
continu organ sale declin forecast organ sale declin
average difficult comparison region expect
domest organ sale growth improv bp sequenti domest
organ sale growth vs average growth improv flat yoy
scanner data updat us scanner sale decreas yoy
roughli line level acceler slightli
yr average basi vs scanner data sale growth
remain similar composit yoy volum price
pervas market share loss continu bp yoy vs bp
promot activ pick scanner sale sold promot bp
yoy vs bp histor gap report organ sale
growth us scanner data bp rang gap appear
narrow recent quarter manag indic recent analyst day
sale untrack channel outperform untrack channel market
share gain particularli e-commerc
continu margin pressur project bp yoy gm contract
quarter bp oper margin bp consensu see
favor resin price environ expect overshadow
dissip price impact recent uptick promot activ
believ continu fiscal year reinvest trade support
address competit issu scanner sale promo bp vs
bp last quarter furthermor manag allud fx-relat headwind
recent analyst day pronounc
detail gross margin build emb bp gross margin contract
pressur appear roughli line recent
lower guidanc slight declin gross margin vs previou guidanc flat
slight declin
thought quarter
ep estim line consensu
forecast organ sale declin prior year comparison
driven price/mix volum segment expect clean
line last fiscal quarter driven price/mix volum
household similar last fiscal quarter competit
pressur remain trash bag charcoal lifestyl acceler
organ sale driven improv price yoy vs last
quarter strength salad dress burt bee
deceler growth given challeng comparison
estim oper margin contract bp y-o-i line
bp bp consensu model bp gross margin
contract bp consensu dissip price fx headwind
manag comment would challeng fiscal year
bp benefit lower sg sale
limit organ sale growth potenti vs hpc fundament gap
peer widen expect top-line woe linger given competit
skirmish number product categori sharp contrast benign
environ across rest group recent lower
guidanc appear reason us concern plan increas
promot go forward regain distribut translat full volum
payback deflat top-line growth drive gm pressur long-term
remain cautiou skew low-growth product categori high exposur
competit us market
valuat high mind view valuat ep
unjustifi vs pg much higher top-line growth gm expans ep
growth visibl pg
million except ep
sale
mute stock reaction visibl follow stock drop sinc
result think bar low stock said visibl remain
low guidanc pull full strateg review new ceo
roughli line yoy reflect slight acceler average
growth bp pickup average segment forecast flat
yoy organ sale growth usa average canada average
emea average rest world average
us scanner trend us scanner sale flattish yoy
period compar reflect slight
acceler average basi vs yoy
deceler driven chees combo lunch nut bacon ground
coffe categori broadli speak promot activ declin notic
quarter us scanner sale promot declin bp yoy vs bp
drive averag price across portfolio yoy vs
result sharp volum declin yoy vs
lower ep estim lower ep estim cent
updat neg fx translat impact top line
partial off-set bp increas gross margin project pullback
us scanner promot activ
thought quarter
ep estim cent consensu
forecast organ sale growth volume/mix price
yoy comparison two-year averag basi model bp
acceler vs
forecast bp yoy oper margin contract driven
combin bp gross margin contract sequenti improv vs
bp yoy contract due improv price still yoy
suppli chain cost pressur higher sg still rise histor low
level
weak top-line outlook organ sale declin expect
slight price-driven rebound deep dive us busi
sale highlight leverag low/no growth end market weak
drive profit margin unsustain level believ margin
process reset reason level see continu risk
point price gap vs privat label remain wide ii advertis spend still
well histor level iii recent expect margin
compress expect mainli driven gm compress still leav
core sg wide gap peer
price under-perform trade ev/ebitda discount low
growth packag food peer k/gi believ appropri reflect
million except ep
sale
mute stock reaction ep expect mute stock reaction cl
improv sequenti organ sale growth y-o-i vs
cl best result sinc easi comparison
partial off-set higher fx headwind put pressur ep
organ sale growth easi comparison year ago period
estim organ sale growth would cl best result sinc
albeit aid easi comparison averag basi model
growth vs also note
us/european scanner data growth remain mute believ untrack
channel chiefli pet perform better consist recent quarter
sale growth y-o-i improv modestli vs
growth
average basi cl us scanner data sale growth vs
european scanner data updat cl european scanner data sale
close
average basi cl sale growth
expect unchang guidanc believ cl reiter ep
guidanc -msd y-o-i organ sale growth guidanc toward
higher end
estim updat ep estim tick cent reflect
neg fx also lower estim
reflect higher fx headwind
thought quarter
ep estim cent consensu
forecast cl organ sale growth y-o-i volume/mix
price easi y-o-i comparison two-year averag basi
model organ sale growth vs
organ sale growth forecast driven latin america
easi comparison neg impact brazil trucker
strike impact cl mainli latin america volum
bp africa/eurasia hill pet nutrit asia pacif
north america scanner trend reflect faster untrack channel
sale growth consist recent quarter europ organ sale
forecast oper margin bp y-o-i model bp
gross margin expans price benefit bp fund growth
bp partial off-set fx/commod headwind bp gross margin
expans off-set bp y-o-i increas spend
sale greater invest behind busi model sg
sale bp y-o-i
slower top-line growth histor trend expect organ sale growth
rang long-term cl msd histor trend low end
cl lt target believ cl organ sale growth emerg market
return histor level due heighten competit local
player competit environ well lower inflationari price compar
last year
discount mega-cap peer compel consid weaker top-line growth
outlook cl diminish strateg halo specif believ cl in-lin
valuat ko look high consid superior lt top-line growth outlook
million except ep
sale
sale
posit stock reaction view ep posit catalyst newel stock
improv sequenti organ sale growth solid back-to-school season
ep beat
organ sale growth trend forecast organ sale declin near
midpoint guidanc declin segment forecast
organ sale increas learn develop vs increas
forecast declin outdoor live vs also
anticip declin food applianc vs
new ceo announc ravi saligram join compani
octob new ceo look initi updat long-
term strategi see detail review like earli next year
portfolio divestitur june announc sell unit
state play card compani uspc gener net sale
cartamundi group deal expect close expect
provid updat continu portfolio divestitur program expect
wrap gener addit after-tax proce
realiz date look increment color around time
divestitur updat use proce debt repay vs share
guidanc expect chang key line item guidanc
includ organ sale declin -lsd normal oper margin
improv bp normal ep oper cash flow
guidanc
pt ep estim rais rais ep estim
respect ep consensu driven
forecast tax benefit quarter mention call
wherea consensu model tax expens anticip upsid vs consensu
estim higher top-line confid rais price target
thought quarter
ep estim cent consensu toward
high-end rang
forecast organ sale declin near midpoint
guidanc segment forecast organ sale increas
learn develop vs increas forecast declin
outdoor live vs also anticip declin
food applianc vs
anticip oper margin decreas bp y-o-i in-lin
bp guidanc bp gross margin declin partial off-set
bp lower sg sale assum price increas product
reduct overhead cost partial off-set unfavor impact
inflat tariff currenc increas invest
top-line visibl lower given challeng retail environ top-line visibl
low categori growth remain modest retail landscap remain
challeng cost busi appear high
valuat warrant given lack visibl trade low end
peer pro-forma ev/ebitda look fair consid visibl
around fundament top-line recoveri remain low potenti larg cost
save opportun off-set reinvest risk
posit stock reaction conserv guidanc head despit
best scanner data trend two year continu expect
handili beat consensu revenu estim posit revis fiscal year
rebound us track channel trend track channel
sale increas yoy average yoy
yr average average declin
average distribut track channel measur y-o-i chang tdp
grew y-o-i y-o-i follow declin
y-o-i increas
confid forward outlook
growth outlook outsid us track channel also look sale
growth updat specialti channel includ updat direct-
to-consum intern market
tariff risk given oper outsourc manufactur model
major sourc china look updat commentari
off-set tariff indic expect off-set tariff impact
combin fx benefit assum cog
import china currenc move hsd ep benefit vendor
concess select price action commun
rais estim rais revenu estim
ep estim due favor
scanner data rebound believ indic guidanc far
conserv revenu ep estim
consensu respect fy revenu ep estim
consensu respect
rais price rais price target
acceler y-o-i scanner trend ep estim increas
thought quarter
ep estim cent consensu estim
forecast flat organ sale growth vs
comparison growth ex retail store closur rebound scanner data
sale growth temper guided-to drag pipelin cycl
forecast oper margin contract bp y-o-i driven primarili
larg sg increas bp y-o-i greater brand invest
advertis grow sale well bp gross margin
contract given close retail store
top-line momentum build recent us scanner data improv
driven rebound volum growth due improv distribut veloc
trend well recent price increas across portfolio highlight
estim flat declin revenu appear far conserv
valuat look reason trade ev/ebitda includ stock
compens expens exclud stock compens expens look
fair somewhat compel given anticip above-guid top-line
rebound return robust top-line growth long-term mind
expect mute reaction result expect fiscal unev
market anticip continu weak
organ sale growth forecast currenc neutral sale declin
y-o-i vs divis forecast growth luxuri vs
profession model flat growth vs declin
profession continu experi repercuss suppli chain
headwind loss share salon consum beauti model
declin vs
scanner updat us track channel data track total
compani sale sale growth
average vs average y-o-i average
europ scanner sale
average vs y-o-i average declin
outlook updat juli analyst updat issu financi target
focu restor profit de-lever stretch balanc
sheet enabl step commerci invest plan
address number histor concern stock includ
step plan p/r invest believ need
reinvigor sale princip consum beauti divis sale
difficulti low visibl turn around busi mind
underscor lt revenu growth guidanc continu believ
brand portfolio need increment invest visibl still low
around execut plans/high spend enough consum beauti
maintain share also point under-expos high growth
key lt concern us
fy estim ep estim remain ep
estim fall unfavor fx
thought quarter
ep estim cent consensu
forecast yoy currenc neutral sale declin driven
growth luxuri declin consum beauti flat growth
forecast oper margin increas bp y-o-i driven bp
gross margin expans driven price mix sg bp
sale led higher advertis net model y-o-i increas oper
mute top-line growth outlook view point behind new
manag team turnaround plan credibl visibl low
maintain market share given uncertainti around payoff higher spend
competit industri execut risk skew within high growth beauti
segment lower growth geographi channel retail
valuat look fair reflect earn visibl high leverag
ebitda ep trade valuat discount
hpc compani attract beauti peer believ properli
earn visibl high net debt/ltm ebitda leverag
neg stock reaction expect neg stock reaction ep
expect soft profit perform coffe behind time vs step
market concern price recent stock
under-perform believ profit/ep miss vs consensu caus neg
reaction consid high debt leverag high risk profil
slow y-o-i vs
averag basi us scanner data sale
close
categori basi scanner data sale growth carbon soft drink csd
y-o-i price/mix growth partial off-set
volum vs
us singl serv coffe volum growth deceler volum growth us
single-serv coffe categori track channel deceler vs
although believ untrack
channel acceler averag basi volum growth
brewer
innov front look commentari initi result k-duo new
coffe brewer function brew larg cup coffe
tradit drip system addit single-serv cup k-cup pod
retail price front appli see us singl serv coffe
price/mix vs
howev flag low visibl kgm price driven lack price detail
contract coffe partner long-term contract partner
scanner data price trend partner retail reflect
coffe system top-line profit trend expect softer top-line trend
coffe system behind revers time benefit pod brewer sale
worth estim bp coffe system sale
bp total sale growth well slowdown us track channel
data albeit partial off-set faster untrack channel growth result
model slowdown y-o-i organ sale growth coffe system
also expect soft coffe system margin
model bp y-o-i vs prior bp step market behind
k-duo warn recent investor confer
guidanc believ reiter ep guidanc rang
rang top-line growth recent lower
prior septemb investor confer
estim updat ep estim fall cent reflect lower
organ top-line growth estim vs prior lower
margin coffe bp y-o-i vs prior bp time
market invest coffe brewer
thought quarter
expect ep cent consensu
forecast organ sale y-o-i growth prior
organ sale growth forecast driven organ sale growth latin
america beverag organ sale growth beverag concentr
prior packag beverag prior
coffe system impact shipment time discuss
forecast om expand bp y-o-i expect gm
bp y-o-i solid price csd cost synergi model
bp y-o-i decreas sg sale less bp decreas
driven cost synergi well legaci kgm/dp product save partial
off-set step market advertis spend coffe system
believ single-serv coffe penetr matur forecast household
penetr growth single-serv brewer slow msd vs market
expect hsd growth support find alphawis survey
includ us single-serv penetr alreadi high base
survey non-own like purchas single-serv
brewer awar keurig system alreadi high
potenti risk synergi see potenti risk synergi target
expect drive major
profit forecast synergi target legaci dp sale look aspir
given littl product overlap dp product kgm product
also assum synergi flow bottom line
rare achiev histor cpg transact note howev
manag strong track record cost save
risk-reward neg skew view risk/reward neg
downsid risk/reward skew base dcf analysi high level assum
ebitda multipl legaci dp busi discount
ko/pep multipl synergi market price impli
ebitda multipl keurig busi look high view also
focu ev/ebitda multipl price-to-earnings given high debt leverag
mute stock reaction us scanner data trend import expect
mute stock reaction earn sale trend
neg impact cycl pre-buy ahead last year monster price
increas net extra sell day howev see bi-weekli scanner data
result us import stock trajectori given volatil retail
sale trend reign innov competit environ energi
us growth impact cycl advanc purchas net extra day sell
day model us sale growth y-o-i vs
bp us scanner data trend reflect cycl
advanc purchas ahead monster novemb price increas worth
bp net one extra sell day quarter worth bp
benefit reign pipelin fill august launch
yr averag basi model growth close
us scanner data market share updat us track channel retail
sale increas y-o-i includ reign average
close average average
average exclud contribut reign
bp base busi
impli high level cannib reign us
market share bp y-o-i us track channel data vs
bp bp bang gain bp y-o-i market share
energi drink categori vs bp bp
howev bang market share stall sequenti end in-
line end
growth y-o-i average
average average
average although two-year averag line recent trend
growth ex-fx report basi prior
reflect higher fx headwind slower european scanner data trend vs
ex-fx ex-fx averag basi model
intern ex-fx sale growth vs
octob monthli sale commentari expect octob preliminari gross sale
low-double-digit rang consid difficult comparison octob
gross sale y-o-i benefit advanc purchas ahead
novemb price increas ad point growth octob
underli gross sale y-o-i exclud advanc purchas ex-
estim updat ep tick cent reflect lower
intern sale growth higher fx headwind lower underli sale
assumpt reflect weaker european scanner data ep also fall
cent reflect lower assumpt
thought quarter
ep estim cent consensu prior
reflect lower intern sale growth assumpt
forecast y-o-i net sale growth ex-fx us
y-o-i ex-fx fx headwind total
compani sale growth averag basi ex-fx model growth
close call august mention total
compani juli gross sale y-o-i ex-fx benefit
addit sell day make juli fx-neutral revenu growth
forecast oper margin bp y-o-i model bp
y-o-i gross margin expans reflect benefit us price increas
favor commod partial off-set neg countri product
mix model oper expens sale flat y-o-i bp
decreas sell distribut expens off-set higher stock-bas comp
 expens
robust top-line growth forecast lt revenu compound-annual-growth-rate us
intern favor demograph trend drive categori growth
competit ramp bang us success along launch coca cola-
brand energi product europ competit risk
consensu
expect in-lin quarter expect deliv in-lin quarter
expect benefit cloverhil acquisit compani
leverag expand breakfast platform expand new channel
club top-line growth also driven list price increas
optim price pack architectur recent breakfast innov hostess danish
snack pack donett improv merchandis howev expect one-tim
headwind includ bp pull-forward sale
mm impact mainten time measur channel data point
strengthen sale basi
acceler rel yoy sale growth stronger volum
yoy off-set modest price/mix declin yoy
cloverhil integr transform success
execut cloverhil integr turnaround profit improv
toward break even follow elev loss expect cloverhil
profit continu ramp model mm profit quarter
also leverag cloverhil distribut footprint enter new store format
club capabl grow breakfast platform recent hostess
success new product launch pipelin look updat
upcom innov pipelin also leverag data analyt
improv custom manag expect initi support top-line growth
come quarter
updat strateg initi outlin number strateg initi
quarter includ open new offic chicago move distribut
thought quarter
ep estim line consensu
forecast net sale growth top-line estim vs
consensu reflect growth sbg/other busi
contribut cloverhil expect moder top-line growth
due pull forward merchandis activ
headwind downtim relat manufactur line mainten
forecast gross margin increas bp y-o-i model bp
yoy gm increas lower input cost cloverhil tailwwind
overal model ebit mm vs consensu mm ebit
estim reflect higher market support platform innov
ep estim consensu
forecast net sale growth top-line estim
consensu reflect growth sbg/other busi
mm contribut cloverhil
forecast gross margin increas bp y-o-i model
bp y-o-i gm increas benefit product program
lap elev input cost inflat
overal model ebit vs consensu mm
advantag growth profil face risk slow categori share trend
expect deliv lsd mid-term organ sale compound-annual-growth-rate msd
outlook given slow categori trend weaker share momentum
compani continu grow packag food peer
margin expans limit reinvest back busi gross
ebitda margin alreadi benefit aggress post-bankruptci
restructur shift warehous distribut compani
implement new initi reloc distribut center reduc
cost plan reinvest save behind top-line growth offer minim margin
potenti accret mitig leverag snack focu
like lever valu creation given compani focu acquisit adjac
categori see potenti hsd ep accret view prospect
limit high leverag competit landscap
premium packag food peer warrant maintain price target
pt base price-to-earnings reflect premium food
peer given rel stronger top line ep growth ev/ebitda
basi appli multipl in-lin peer given twnk rel higher
leverag see balanc risk reward downsid bear case
upsid bull case
million except ep
sale
thought stock reaction believ stock reaction fiscal ep
mute given unfavor scanner data quarter wet shave alreadi
reflect low expect stock despit favor sun care
market focus pend harri deal
organ sale growth forecast y-o-i organ sale growth
comparison mute top-line reflect challeng price competit
environ model wet shave organ sale sun skin
organ sale feminin organ sale
harri deal may announc acquisit harri
compani expect close end calendar
concern high degre risk transform acquisit
harri ltm sale mix time proceed
larg cost-cut program look divest infant manag
base busi weak risk also heighten high pro-forma debt
leverag manag chang harri team take manag
us brand potenti turnaround around heritag brand
requir differ skill set histor acumen grow
harri busi still profit said believ bring
intern distribut platform harri well scale
 d/technolog platform harri bring e-commerc dtc direct-to-
consum knowledg omni-channel expertis manag team
proven acumen develop harri brand
scanner data updat us heritag track channel sale trend acceler
average vs average
average wet shave scanner data
vs feminin scanner data
vs sun care scanner data
vs european scanner data
sale vs
potenti sun improv sun us
scanner data categori grown lost bp
market share estim uptick sale growth sun care
categori larg attribut weather summer less rain
higher temperatur despit guid continu consumpt
headwind quarter
project fuel continu expect increment gross save
project fuel lead eventu gross save
end estim onetim pre-tax charg approxim
addit capit invest end
lower ep estim lower ep
lower fx estim drag top-line
thought quarter
expect ep cent consensu
forecast y-o-i organ sale prior year comparison
model wet shave organ sale sun skin
also model organ sale feminin organ
sale
expect oper margin decreas bp y-o-i driven bp
decreas gross margin unfavor product mix increas product
cost model total sg bp sale bp
 bp sg bp
combin organ heritag lsd harri
weak overal compani categori growth competit industri
environ harri gain share small base
high degre risk see risk high combin compani
transform acquisit harri ltm sale mix time
proceed larg cost-cut program look divest larg
piec heritag busi fem infant manag
base busi weak risk also heighten high pro-forma
debt leverag ex synergi manag chang harri team take
manag us brand potenti turnaround around heritag
brand requir differ skill set histor acumen grow
harri busi still profit
valuat look fair trade pro-forma ev/ebitda
lower end hpc peer view valuat fair given high degre risk
million except ep
sale
stock reaction expect mute stock reaction ep market
benefit hurrican shipment volum howev expect anoth
neg guidanc revis albeit telegraph earn stock
risk amplifi high debt leverag
sale y-o-i average vs
average average
average legaci energ us scanner data trend impact
volum relat hurrican dorian scanner data sale two week
end y-o-i revers follow two week end
sale y-o-i
busi us scanner data trend improv also impact hurrican
volum us track channel sale rayovac brand y-o-i
average vs average
average average rayovac us scanner data sale
two week end y-o-i aid hurrican volum
revers y-o-i sale declin two week end
remain weak although note signific portion busi sold
untrack channel us track channel sale decreas
average vs average flat average
western europ scanner data european scanner data sale includ
acquir batteri busi ex-varta decreas y-o-i
average average
average average
guidanc provid updat outlook alreadi
lower guidanc auto care busi earn
revis previous provid outlook auto care sale
rang vs prior indic remain
batteri light busi total busi stabl grow
revis impli net sale rang vs on-consensu
compar prior guidanc also expect
revis ebitda guidanc vs
estim consensu prior guidanc
reflect lower sale impact partial off-set approxim
increas synergi benefit indic net expect lower
ep guidanc vs estim consensu
prior
estim price target updat ep estim move cent
reflect higher organ top-line outlook vs prior
reflect shipment benefit hurrican relat volum howev
ep estim tick higher fx headwind
thought quarter
expect ep prior cent
model y-o-i organ sale growth vs guidanc
driven growth america aid hurrican shipment volum
cycl easi comparison
forecast oper margin bp y-o-i lower gross
margin acquir busi model gm bp y-o-i close
bp declin ytd off-set lower level busi lower
sg cost synergi realiz forecast sg sale
deal integr risk high debt leverag believ deal integr risk
high post announc acquisit batteri busi acquisit
auto care given simultan integr two busi
differ categori struggl albeit buyer
similar systems/etc addit concern high pro-forma debt
leverag net debt/ebitda
improv fundament batteri categori forecast long-term
revenu growth outlook base vs hpc peer rang
improv batteri categori evidenc recent updat lt
outlook categori growth flat slightli posit vs flat
lsd prior also believ price environ improv batteri
categori post batteri deal
reason valuat trade ebitda forecast pro
forma basi fulli synerg toward low end hpc peer view
fair given deal integr risk high debt leverag
valuat methodolog risk
pt forecast organ sale growth go forward hpc
peer led improv us result build market share momentum better price
realiz continu cost save support bp om expansion/yr drive
hsd ep growth appli multipl ep slight premium pg
share vacil currenc commod volatil
pt organ sale growth rebound oper
profit margin expand bp driven commod cost fx cost
save price benefit valuat ep histor
averag ntm price-to-earnings
upsid risk includ lower expect commod cost higher birth rate drive
improv categori growth improv market share trend greater price realiz
downsid risk includ greater expect commod pressur price promot
realiz cost-cut downsid strengthen usd
pt forecast organ top-line growth beyond
appli price-to-earnings multipl line multipl appli pg given
strateg potenti cl despit lower top-line growth
upsid risk stronger price greater market share payback ad spend
consolid potenti increas
downsid risk weaker price market share loss local player
categori growth slowdown stronger usd higher commod cost strateg
pt organ top-line growth ebit growth organ sale
growth beyond oper margin bp annual
top-line growth price cost save valuat expand ep impli
downsid risk volum recoveri lower price weaker price due lower
inflat em volum pressur categori weaker margin expans
higher reinvest dissip strateg potenti
upsid risk greater strateg potenti rebound volume/market share
pt forecast organ top-lin growth organ
price-to-earnings ccep histor price-to-earnings reflect improv fundament
upsid risk ccep complet accret acquisit new territori margin upsid
lower expect commod cost higher contribut innov
higher volum growth non-csd brand favor weather drive higher
downsid risk volum pressur health well concern sugar tax
potenti hard brexit unfavor fx movement higher expect commod
cost inflat unfavor weather weaker macro condit western europ
pt forecast organ top-line growth hsd ep growth
beyond appli price-to-earnings multipl base case ep cpg peer
driven strong price power ko transform higher growth/roic
concentr model bottl divestitur posit chang new
volatil health well pressur lower expect product soda
pt organ sale growth driven solid snack growth
om expand bp annual post reinvest cost save assum
price-to-earnings lt histori reflect higher top-line growth visibl
in-lin multipl mega-cap cpg peer
risk includ russia/mexico/china volatil commod cost fx volatil lower
expect cost save restructur program acceler competit
intens beverag soda tax macro and/or health-rel top-line weak
price target organ sale growth rang realiz
full synergi reach ebit margin appli
price-to-earnings ev/ebitda discount back cost equiti support
base case dcf analysi
upsid risk upsid dp synergi target higher expect volum growth
coffe higher household penetr growth better coffe pod price base
keurig long-term contract dp price upsid csd higher top-line contribut
allied/licens brand
pt e-commerc china travel retail drive strong organ revenu
growth lt top-line growth cost-cut top-line leverag drive annual
underli margin expans bps/year appli ebitda
risk includ china result slow tariff/boycott risk ad claim risk categori
unfavor fx
pt organ top-line rang continu declin
us/canada bp margin expans larg driven cost save drive flat
ebit compound-annual-growth-rate though dcf input includ wacc termin
growth rate well npv tax relat benefit
risk includ us beer industri volum trend price environ cost-cut
upside/downsid commod tax law chang fx macro risk
pt organ sale growth rebound vs flat
oper margin contract bp cost pressur
reinvest bp valuat expand ev/ebitda
impli ep rebound near-term topline/profit growth
upsid risk includ higher-than-expect us snack growth reinvest
dsd save stabil us cereal busi innov higher ad
spend higher margin expans greater cost save moder commod
strateg potenti
downsid risk includ volum pressur consum shift healthier food
option price pressur us sale retail friction lower
oper profit growth higher reinvest need higher cost pressur
pt forecast lt organ top line growth bp averag
margin expans expect valuat ep roughli one half
standard deviat averag reflect competit risk
risk includ top-line margin upsid improv price better expect
volum declin commod cost consolid potenti cost-cut
pt deliv average org sale growth slightli
long-term target appli price-to-earnings base case ep
standard deviat last averag strong organ
upsid risk includ organ sale growth sustain rang greater price
lower commod product higher expect potenti accret
acquisit consolid
downsid risk includ competit price us promot intens key
categori ramp us volum downsid privat label share gain increment
commod inflat execut risk
pt follow expect ebitda declin model
stabil start ebitda compound-annual-growth-rate growth outsid north
america mostli off-set continu weak us/canada dcf input
revenue/ebitda compound-annual-growth-rate post wacc tgr exit
risk includ us food industri volum trend price environ increment
cost-cut upside/downsid commod strateg potenti sector rotat
pt deliv lsd organ sale growth follow expect
lsd declin cost save drive om expans
appli ebitda in-lin secularli challeng name epc/tap
commod cost tariff risk fx
pt forecast lsd organ sale growth legaci l-msd
ebitda growth ex fx realiz midpoint synergi target appli
ev/ebitda multipl fulli synerg ebitda close averag
lower qualiti cpg peer
risk includ deterior batteri categori volum greater/low competit
intens lead less/mor price realiz currenc commod cost risk
share gain higher/low expect deal integr risk around
batteri auto care busi deal tariff risk
pt base price-to-earnings premium us food coverag
risk thesi deviat categori growth rel current outlook
market share eros meaning contribut growth new product
innov whitespac higher oper leverag
pt heritag organ sale oper
margin bp forecast slowdown harri busi
recent trend appli ev/ebitda
multipl given weak organ sale growth potenti due sluggish categori trend
highli competit categori well heighten risk
upsid risk upsid project fuel cost save target higher contribut
product innov wet shave sun skin feminin declin
moder shelf space loss market attribut increas
strateg potenti success deal execut harri
downsid risk save execut risk higher expect fx commod
headwind organ sale growth deceler higher price pressur wet
shave higher market share pressur product risk acquisit
pt deliv improv top-line growth post
rebound us trend strong growth e-commerc int market om fall
greater reinvest appli
upsid risk strateg risk given lt expans potenti greater expect
distribut expans success expans skin care
downsid risk competit risk custom concentr risk sourc risk china
cost volatil suppli chain hiccup around tariff higher debt leverag
pt deliv us revenu growth int revenu growth
valuat expand ebitda impli price-to-earnings premium
high growth cpg peer given much higher long-term top-line ep growth potenti
well higher
upsid risk drop plan launch energi drink product strateg potenti
increas price drive margin higher contribut innov includ reign
higher intern sale growth market share gain
downsid risk increas competit bang legal/regulatori risk
lower gross margin product mix/geograph mix higher commod cost us
sale volatil intern margin weaker forecast
pt organ top-line growth remain mute rang pressur
consum beauti off-set steadi lsd growth luxury/profession synergy-l
margin progress drive ebit margin turn ebit compound-annual-growth-rate
dcf input wacc tgr exit multipl
risk includ synergy/cost save realiz suppli chain risk shelf space loss
consum beauti licens chang consum demand/macro risk
